PCN324 Patient Reported Outcomes Among Kte-X19 CAR T Treated Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL)

Authors :: M. José Kersten
Caitlyn T. Solem
G. Maglinte
S. Crawford
Javier Munoz
Arati V. Rao
Noel-Jean Milpied
Michael Wang
Source :: Value in Health. 23:S479
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Health Policy
Internal medicine
Relapsed refractory
Public Health, Environmental and Occupational Health
medicine
Mantle cell lymphoma
Car t cells
medicine.disease
business

Tools